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Aims
Increased afterload in idiopathic pulmonary arterial hypertension (IPAH) causes right ventricular (RV) hypertrophy and failure. Since RV remodeling occurs with alterations in RV oxygen metabolism, increasing our understanding in the factors determining RV O 2 consumption in IPAH is necessary. In the left ventricle, it is known that heart rate and systolic blood pressure are the main determinants of myocardial O 2 consumption (MVO 2 ). However, the normal right heart has lower oxygen extraction and perfusion than the left myocardium and RV energy metabolism is changed in hypertrophy. Therefore, it is not obvious that the relations of pressure and heart rate to MVO 2 hold for the overloaded human right heart. We hypothesize that systolic pulmonary artery pressure (PAP) and heart rate (HR) are the major determinants of RV MVO 2 in IPAH.
Methods
In eighteen IPAH patients (NYHA class II and III), RV MVO 2 was determined using positron emission tomography and 15 O-tracers. PAP and HR were measured during right heart catheterisation.
Results
RV MVO 2 related to systolic PAP (R 2 =0.54, p<0.001), inversely to stroke volume (R 2 =0.32, p=0.015) and HR (R 2 =0.32, p=0.014). Relations of MVO 2 with the Rate Pressure Product (RPP), i.e., systolic pressure times HR, and wall stress were R 2 = 0.55, p<0.001, and R 2 =0.30, p=0.020, respectively. Multiple regression of MVO 2 on HR and systolic PAP gave R 2 =0.59, p=0.001.
Conclusion
Systolic PAP and heart rate are the major determinants of RV MVO 2 in IPAH. Further increase of heart rate and PAP with IPAH progression suggests a compromised RV myocardial oxygen availability.
DETERMINANTS OF OXYGEN CONSUMPTION IN IPAH intrOduCtiOn
In the face of an elevated pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) in idiopathic pulmonary arterial hypertension (IPAH), right ventricular (RV) workload increases, which in turn causes RV remodelling with hypertrophy and dilatation. The larger ventricular workload demands a higher cardiac metabolism and thus augmented myocardial O 2 consumption (MVO 2 ). In theory, if the MVO 2 in the hypertrophied right ventricle is elevated, a further increase in MVO 2 is restricted due to limitations in oxygen supply, 1-3 RV pump function will be limited, which may contribute to the development of in fatal RV failure. It is therefore of crucial importance to gain more insight into the determinants of MVO 2 for the diseased RV myocardium.
In the normal and the diseased left ventricle, it is accepted that MVO 2 is related mainly to two haemodynamic variables, heart rate (HR) and systolic blood pressure. [4] [5] [6] [7] [8] The product of HR and systolic pressure is called the heart rate (blood) pressure product or simply the rate pressure product (RPP) and is an accepted haemodynamic indicator of MVO 2 . [4] [5] [6] [7] [8] It is assumed that similar relationships of HR and pressure to MVO 2 exist in the right ventricle since the parameters of RV MVO 2 are difficult to measure. 9 From experimental studies in animals it is known that in the normal right heart the oxygen extraction and coronary flow are much lower than in the left myocardium. 10, 11 In chronic RV hypertrophy, experimental studies report an elevated oxygen extraction 11, 12 whereas other studies observed conflicting baseline right coronary flow or perfusion. 3, [12] [13] [14] It is thus not clear if pressure and HR are the main determinants of MVO 2 of the human diseased right myocardium secondary to IPAH.
The present study was conducted to investigate these relationships in a population of IPAH patients. We determined the MVO 2 of the hypertrophied and failing right ventricle in vivo using state-of-the-art positron emission tomography (PET). We related the RV MVO 2 to systolic PAP, HR and their product. The associations with stroke volume and RV wall stress were also investigated.
MethOds study design
Between April 2008 and October 2010, patients with IPAH with World Health Association (WHO)-adapted New York Heart Association (NYHA) class II (n=9) and III (n=9) were included. All were under optimal treatment, except for one with NYHA class III who was newly diagnosed and included prior to the start of treatment. Exclusion criteria were: a history of coronary vascular disease, atrial fibrillation and anaemia (haemoglobin <12g/dL). During the study protocol, single or combi-treatment with a phosphodiesterase type-5 inhibitor, endothelin receptor antagonist or i.v. prostacyclin was continued. All patients underwent a right heart catheterization (RHC) and a cardiac magnetic resonance imaging (cMRI) within the scope of follow-up or diagnosis. To determine RV MVO 2 , patients underwent a PET study using three consecutive 15 O-scans. Except for three patients, all examinations, including PET, were performed within 1 week. For logistical reasons, in these three subjects the interval between RHC and PET was 20, 29 and 55 days, and between cMRI and PET it was 20, 29 and 36 days. Because all three had stable IPAH under drug treatment, this prolonged interval was considered acceptable. The study was approved by the Medical Ethics Review Committee of the VU University Medical Center. All patients gave written informed consent prior to inclusion.
right heart catheterization
The protocol has been described in detail elsewhere. 15 Briefly, under continuous ECG monitoring, a balloon-tipped, flow-directed 7.5F Swan-Ganz VIP+ catheter (834HF75, Edwards Lifesciences Corporation, Irvine, CA, USA) was inserted in an internal jugular vein and moved to the main pulmonary artery. Cardiac output was measured by means of thermodilution. Pulmonary vascular resistance (PVR) was calculated as the difference between mean PAP and pulmonary capillary wedge pressure divided by cardiac output.
Cardiac magnetic resonance imaging
Scans were acquired on a 1.5T Sonata scanner or a 1.5T Avanto whole body scanner (Siemens Medical Solutions, Erlangen, Germany) according to the scanning protocol previously described.
3 RV volumes and mass were measured from the stack of short axis images by manual detection of the endocardial and epicardial borders of the right ventricle on each slice using the MR-Analytical Software System (Media, Leiden, The Netherlands). Right ventricular free wall mass was calculated at end-diastole and end-systole by multiplying the RV free wall volume by 1.06. 15 Luijnenburg et al. determined the inter-observer variability of RV free wall mass, which was 6.2%, using a stack of short-axis cine images acquired with steady-state free precession imaging similar to our present study. 16 It was also addressed by Bradlow et al., who reported a variability coefficient of 14.2%. 17 The RV end-diastolic volume was also determined; 15 the RV ejection fraction was derived as the ratio of stroke volume to RV end-diastolic volume.
positron emission tomography protocol PET scans were performed 2 hours after a light breakfast. Patients received a cannula in the radial artery for blood sampling and a cannula in the radial vein for tracer injection. image processing and data analysis
All emission data were reconstructed as previously described. 18 The anatomical tissue fraction, generated by subtracting the [
15 O]CO blood pool image from the transmission image, 20 was resliced into short-axis images according to the anatomic axes of the left ventricle. The same reslicing parameters were applied to both dynamic [ 15 O scan and in which a correction for spillover from activity in the pulmonary gas volume was applied as described previously. 22 The [ 15 O] O 2 input function was based on the volume of interest drawn in the ascending aorta and was corrected for the contribution of recirculating water as measured in the arterial blood samples. Any small inter-individual differences in the size of the ventricular regions of interest were corrected by the perfusable tissue fraction and spill-over fraction in the tracer kinetic models.
Myocardial oxygen consumption of the RV free wall (mL/min/g) was calculated as follows:
where CaO 2 is the arterial O 2 content (mL O 2 /mL blood), calculated from the product of 1.39 (conversion factor), haemoglobin (g/mL) and O 2 saturation (fraction), 20 leaving out the term 0.003P aO2 since it is negligible. To obtain oxygen consumption and blood flow for the whole RV free wall, the data per gram were multiplied by the (end-diastolic) RV mass (in grams). The RPP of the right ventricle is the product of systolic PAP and HR determined by RHC.
The RV wall stress was estimated according to an adaptation of the Laplace's formula by Arts, 23 in which end-systolic ventricular volume and wall mass obtained from cardiac MRI, instead of the ventricular radius and wall thickness, were used:
where P systole is the systolic PAP, RV wall ES is the end-systolic RV free wall mass and RV lumen ES is the end-systolic RV volume.
statistical analysis
All results are expressed as mean ± SD. Pearson's correlation and multiple regression analyses were performed where necessary. P<0.05 was considered significant.
resuLts
A total of 18 patients were included in the present study with a wide range of disease severity from mild IPAH to severe IPAH with RV failure. The patients' characteristics and haemodynamics are shown in Table 5 .1.
For the total population, the arterial O 2 content was 0.18 ± 0.02 mL O 2 / mL blood. Using PET, the mean O 2 extraction fraction (OEF) was found to be 69 ± 17% and the mean perfusion (MBF) was 0.92 ± 0.30 mL/min/g; mean RV MVO 2 was 0.079 ± 0.018 mL/min/g.
The MVO 2 of the whole RV wall correlated significantly with the systolic PAP ( Figure 5 .1A) and the HR (Figure 5 .1B). RV MVO 2 and stroke volume were inversely related ( Figure 5.1C ). e RVwall ES RVlumen ES Linear multiple regression analysis with only systolic PAP and HR gave: RV MVO 2 = 6.52·10 -2 sPAP + 4.47·10 -2 HR-2.74; R 2 =0.59, p=0.001. Inclusion of the stroke volume in the multiple regression analysis did not increase the explained variance. The product of systolic PAP and HR, RPP, resulted in a relationship to RV MVO 2 that was, in fact, similar to the above-mentioned multiple regression formula ( Figure 5.1D) . Furthermore, a similar relationship was also found between PVR and the whole RV MVO 2 (R 2 =0.53, p=0.0002). No relationship between RV mass and MVO 2 per gram right ventricle was found (p=0.13), and also no significant relationships existed for the above-mentioned parameters with MVO 2 per gram right ventricle.
Mean systolic RV wall stress was 48 ± 11 kPa. The wall stress correlated with MVO 2 of per gram right ventricle (R 2 =0.29, p=0.020).
disCussiOn
We show that the systolic PAP and the HR are indeed the major determinants of MVO 2 of the hypertrophied right ventricle in IPAH patients. The combined measurements of RPP -not surprisingly -and RV systolic wall stress also have a linear relationship with RV MVO 2 , but do not improve the relationship with systolic PAP and HR. In severe IPAH with RV failure, both systolic PAP and HR are known to be elevated. 24 In general, the systolic PAP equals the systolic RV pressure. Therefore, either one of the systolic pressures may be used in practice. The finding that HR and pressure are related to RV MVO 2 is consistent 7 In addition, Katz and Feinberg also observed a relationship between the RPP and LV MVO 2 . 8 Since then, these observations have been validated in healthy subjects 4, 6 as well as in patients with left heart disease, 25, 26 during both resting and exercise conditions. The present correlations between RV MVO 2 and both HR and systolic pressure appear to be weaker than for LV studies. The weaker correlation could have a methodological cause, e.g. because the PET technique requires the determination of RV mass. In addition, intrinsic myocardial differences between right and left ventricles may contribute to the observed differences, for instance the basal MVO 2 . It may be possible that intrinsic myocardial differences, e.g, in the basal oxidative metabolism, are different between right and left ventricles, which could explain the observed differences. Furthermore, recent studies reported RV perfusion limitations in severe pulmonary arterial hypertension (PAH).
1-3 However, as care was taken to exclude patients with coronary artery disease and RV OEF was 69 ± 17%, it suggests that resting RV ischaemia was not present in our study population and therefore did not affect MVO 2 .
From a physiological point of view, cardiomyocytes do not sense ventricular (systolic) pressure, but generate stress, which is an argument to relate (systolic) stress to oxygen consumption. For this reason, we evaluated whether wall stress was better associated with MVO 2 than with systolic pressure. Instead of the usual Laplace's method, we choose the adapted Arts formula to reduce the local variability in ventricular radius and wall thickness throughout the right ventricle in IPAH. 23 This formula circumvents the problems in the measurement of (local) curvature and local wall thickness. By not incorporating the septal mass a systematic error may be introduced, but the correlations are not affected. Both methods yielded comparable wall stress estimations (data not shown). In general, the Laplace's law holds that, at a certain pressure, increased wall thickness reduces wall stress, while ventricular dilatation increases it. Previous studies indeed demonstrated a close relationship between LV MVO 2 and increased systolic wall stress in cardiac hypertrophy secondary to aortic stenosis. 27 In addition, it has been reported that the RV systolic wall stress in IPAH patients was higher than in controls. 28 The present study completes this aspect, as we demonstrate a significant correlation between systolic wall stress and MVO 2 of the hypertrophied right ventricle in IPAH. This was, however, weaker than with the systolic PAP. The fact that wall stress has no better association with MVO 2 than systolic blood pressure has also been observed for the left ventricle. 5 There was also a significant association between PVR and RV MVO 2 . This, however, is not surprising as PVR is largely derived from PAP, which is correlated to RV MVO 2 ( Figure 5.1A) . Furthermore, the RV afterload consists not only of resistance but also of compliance. This compliance load (or the oscillatory power) contributes to a significant proportion to the RV load and recently we showed that it is also proportional to, and thus dependent on, the PVR in IPAH patients. 29 One animal experimental study group reported a relationship of RV MVO 2 to RPP and RV systolic pressure in a pulmonary artery constriction canine model, but no correlation was noted with HR. 30 Since they used an anaesthetized open-chest model this may have affected their observations. 9 In spite of the fact that RPP has proven to be an excellent index for MVO 2 elsewhere (r=0.90), 4 it is by definition not an energy parameter. 5 Nevertheless, the multiple regression analysis that includes stroke volume together with systolic PAP and HR did not improve the correlation with MVO 2 , compared to the RPP or the combination of systolic PAP and HR (see the Results). Surprisingly, a lower stroke volume was associated with a higher RV MVO 2 , and vice versa. Haemodynamically, this can be understood as the low stroke volume is related to a high HR, thereby reflecting the severity of IPAH. Sarnoff et al. demonstrated experimentally that when all other parameters were kept constant, changes in stroke volume had little influence on the LV MVO 2 .
7 Thus, it can be concluded that the systolic PAP and HR are the major determinants of MVO 2 of hypertrophied right myocardium in PAH. Fortunately, these are in practice the most easily obtainable measures during the follow-up of IPAH patients.
Because RV venous oxygen content cannot be obtained due to lack of a common venous drainage independent of that of the left ventricle, determination of RV MVO 2 in situ using the Fick method is extremely difficult. So far, it has only been achieved in experimental studies in which the animals underwent an open-chest operation to catheterize the small RV venous vessels prior to the experiment. [10] [11] [12] 30 However, PET, together with on-site-produced shortlived 15 O-tracers, enables quantification of MVO 2 of the hypertrophied right ventricle in IPAH. 19 
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DETERMINANTS OF OXYGEN CONSUMPTION IN IPAH implications
Results of this study indicate that the right ventricle consumes more oxygen when the HR and/ or systolic PAP increase. An increase in HR and/or PAP, as can be observed in progressive IPAH, therefore is predicted to elevate RV oxygen demand. Conversely, reduction in the pulmonary arterial stiffness could lower RV MVO 2 since this lowers the RV afterload and thus the pressure, as has been shown recently for the left ventricle. 31 In IPAH, however, the primary therapy to reduce pulmonary arterial stiffness and thus RV MVO 2 would be lowering the PVR. Moreover, emerging evidence shows that increased HR and an over-activated sympathetic nervous system have a negative prognostic influence on the survival of patients with IPAH. 24 32 We therefore postulate that reduction in the HR and/or PAP, by reducing PVR, is likely to improve the balance between myocardial supply and demand for oxygen. Since the present study only investigated the RV MVO 2 at baseline, future studies are warranted to include interventions in reducing HR or systolic PAP to study their effect on the RV MVO 2 . Groepenhoff et al. showed that during exercise in patients with PAH, HR increases rather than stroke volume, while in left heart failure (LHF) the inverse was found. 33 On the basis of our present findings we predict that, at comparable exercise levels, right heart MVO 2 will increase more in patients with PAH than in LHF patients. Boilson et al. showed that in LHF with preserved ejection fraction, pulmonary vasodilation with nitric oxide (NO) did not reduce (systolic) PAP, since capillary wedge pressure increased. 34 Our present results suggest that, since NO does not lower RV pressure, the high MVO 2 also will not be reduced by NO.
Limitations
With only one male patient, our study population represents the known female predominance in IPAH. This male patient, however, had haemodynamic parameters and MVO 2 values similar to the mean values of the whole study population. Unfortunately, due to the limited thickness of the normal RV myocardium, no information on relationships in normal human subjects could be obtained. Nevertheless, by extrapolating open-chest studies in normal dogs and dogs with RV hypertrophy secondary to pulmonary arterial banding, a considerably larger oxygen extraction and consumption in IPAH patients can be expected. [10] [11] [12] 30 [ 15 O]H 2 O-PET is considered to be the gold standard for determining myocardial perfusion in vivo. 35 Recently, we showed that the OEF, needed in the calculation of MVO 2 (equation 5.1), is reproducible using the present methodology. 19 Obviously, the various PET-derived parameters contain measurement errors that may explain a large part of the scatter in Figures 1A-D .
Conclusions
The present study provides basal insights on the oxygen metabolism of the hypertrophied right ventricle, demonstrating that systolic PAP and HR are the major determinants of the RV MVO 2 in IPAH patients.
